Seaweed-Derived Bromoform Additives Approach Commercial Scale
Asparagopsis-derived bromoform additives, which suppress methane production by inhibiting a key enzyme in the rumen fermentation pathway, are moving from small pilot-farm trials toward commercial-scale cultivation and supply as several producers report methane reductions exceeding 80% in controlled feeding trials. Blue Ocean Barns and Symbrosia have both expanded land-based and offshore cultivation capacity since 2023, addressing the seaweed-supply bottleneck that previously limited commercial scaling. This mirrors the scaling path taken earlier by algae-based omega-3 categories, where cultivation technology investment preceded mainstream commercial adoption. At least a dozen dairy cooperatives have launched seaweed-additive feeding trials at commercial herd scale recently.
Market Impact: Covers 72% of Danish dairy herds








